Skip to content

Author

Yong Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

CXCL9 drives lung adenocarcinoma progression and immunotherapy response via activation of the CXCR3/JAK1/STAT3 signaling pathway

Highlights • CXCL9 is upregulated in LUAD responders to PD-L1 immunotherapy.• High CXCL9 expression predicts poor prognosis in LUAD.• CXCL9 promotes LUAD cell proliferation, migration, and invasion.• CXCL9 activates CXCR3/JAK1/STAT3 signaling to drive malignancy.• JAK1/2 inhibitor Ruxolitinib reverses CXCL9-driven mali...

Qing Ju, Xiang-Xiang Chen, Ning Chang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.